Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

If your day-to-day routine is filled to the brim with school drop-offs, 9-to-5 work obligations, trips to the grocery store, after-school tutoring sessions, soccer games, piano practices, and school ...

Which eye problems should parents watch for in children and teenagers? Learn about the five most common conditions and when to act.

First MHRA-approved low-dose atropine eye drop to slow the progression of myopia (short-sightedness) in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of -0.

Shopping for internet service can feel overwhelming when you’re faced with dozens of plans, speeds and pricing options. Every provider promises fast and reliable service, but figuring out what you ...

Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SYD-101 met its primary phase 3 efficacy endpoint, but ...

McConnell’s hemp ban risks wiping out most U.S. hemp-derived products, while MSOs pin hopes on Schedule III rescheduling that ...

MT-125, a selective inhibitor of non-muscle myosin II, targets glioblastoma's tumor proliferation and resistance mechanisms. The FDA's fast track designation aims to expedite MT-125's development and ...

English teacher Mary Rodgers kicked off her 12th grade honors English class at Louisa County High School in Virginia with an activity that some of her colleagues around the country would find ...